D ifferentiated thyroid cancer (DTC) is increasing in
prevalence. In patients over 45 years of age, metastasis to the regional lymphatic system is a potent indicator of the biological behavior and the distant metastatic potential of the disease. As such, adequate evaluation of the lateral neck is essential for better determining the nuances of an individual's disease progression. Furthermore, a comprehensive understanding of preoperative disease status is important because it can be informative for selecting appropriate therapeutic interventions.
The American Thyroid Association (ATA) recommends the routine use of US to assess the lateral neck for metastatic lymph nodes in patients with DTC (1). This is based upon evidence from several studies that have found that patients with US detectable neck metastasis have a significantly worse outcome than those with no metastases (2) or microscopic metastases detected only on histopathology (3) . Others have demonstrated that US increases the detection of nodal disease compared to physical examination alone (4) . Although these studies may demonstrate the usefulness of preoperative neck US in the diagnosis of lymph node metastasis, it is still controversial, if and how much preoperative neck US can improve prognosis.
At our institution, we have traditionally assessed the lateral neck by clinical examination alone and have recently transitioned to a practice of preoperative US assessment. Early adopters within our institution practice preoperative US assessment of the neck while later adopters relied on clinical assessment of the neck over the study period. This unique period of transition provided patients of similar clinical features, similar surgical techniques, radioactive iodine (RAI) use and follow up methods. This graduated change in practice therefore gave us an ideal opportunity to investigate the utility and impact on outcome of preoperative neck US by directly comparing patients who receive a preoperative neck US and those who do not. Our objective was to determine the impact of preoperative neck US on the patient's initial Response to Therapy, postoperative use of RAI and need for additional neck surgery.
Patients and Methods
Following Institutional Review Board approval, 890 consecutive surgical patients with DTC, operated on within our institution between January first 2009 and December 31st 2010, were reviewed from our hospital database. Patients were excluded if they had surgery outside of MSKCC, had clinically palpable neck disease or missing neck examination findings. The primary endpoints was Response to Therapy. Response to Therapy was developed to determine patients' likelihood of disease recurrence based on response to treatment as measured by serum thyroglobulin levels and regional imaging studies. To allow for this, patients with less than total thyroidectomy, distant metastases at presentation, no follow up thyroglobulin (Tg) or Tg antibody were also excluded. This left 465 patients for analysis (Figure 1) . Patient, tumor and treatment characteristics were recorded. Patient characteristics included age and gender. Tumor characteristics recorded included tumor histology, primary tumor size, presence of extrathyroid extension or vascular invasion, number and site of lymph nodes resected. All patients had total thyroidectomy. At our institution, we do not carry out prophylactic central neck dissection (CND) or lateral neck dissection (LND) in patients with a clinically N0 neck. Assessment of the lateral neck is performed by palpation at preoperative clinical visit or by preoperative US. Assessment of the central compartment for all patients is intraoperative palpation of the central compartment lymph nodes at the time of thyroidectomy. If no palpable nodes were present in the central compartment, then elective CND is not performed. If nodes are palpable and confirmed to have cancer on frozen section, then a central compartment neck dissection is carried out. N0 stage was defined if nodes were removed and found to be benign on pathology (pN0) or if no nodes were suspicious on palpation during surgery and therefore not removed (Nx). We have recently published our data on management of the clinically negative neck (5) reporting that N0/Nx have similar outcomes. Others have also demonstrated that Nx have very low incidence of recurrent/persistent disease, comparable to N0 groups.
Postoperative treatment details recorded were use of . Postoperative thyroid stimulating hormone (TSH) suppression is practiced for all patients, aiming for a level of between 0.1-0.5 mcUnits/ml. All patients had follow up with Tg and postoperative ultrasound. Survival outcome was classified using the AJCC staging system and recurrence risk classified using the ATA risk group stratification.
The primary end point was initial Response to Therapy. Response to Therapy was defined as no evidence of disease (NED), biochemical persistent disease or structural persistent disease, as per previously published risk of recurrence stratification (6) . Patients were considered to be NED if they had a suppressed serum Tg Ͻ 1 ng/mL, no detectable Tg antibodies, and no structural evidence of disease on ultrasound assessment. Patients with persistent disease were further classified as having either biochemical evidence of disease (elevated Tg values alone without structural correlate) or structural evidence of disease (elevated Tg values with structural correlate on ultrasound)
The presence of local or regional structural disease recurrence following treatment was based on cytological or histopathological confirmation of structurally identifiable disease. The median follow-up for the entire patient cohort was 29 months (range 1-52 months).
Patient, tumor and treatment variables were compared within groups using Pearson's chi squared test. A p value less than 0.05 was considered significant. Statistical analysis was carried out using JMP statistical package (SAS Institute Inc. SAS Campus Drive, Cary, NC 27513) and SPSS (IBM Company Headquarters, 233 S. Wacker Drive, 11th Floor, Chicago, Illinois 60606).
Results
The median age of the cohort was 48.7 years (range 14 -84 years) and 337 were female (72.4%). Two hundred and thirty four patients (50.4%) had a preoperative ultrasound evaluation of cervical neck lymph nodes and 231 patients (49.6%) did not. Patient demographics stratified by preoperative neck US status are shown in Table 1 . There were no significant differences in age, histology, T stage, postoperative RAI dose, AJCC stage, ATA risk category or duration of follow up between the 2 groups. The N1a and N1b patients were more likely to have T3T4 tumors as one would expect. There was no difference in the histologic subtypes between patients who were N0/ Nx, N1a and N1b.
Rate of neck dissection
Management of the neck stratified by preoperative US is shown in Figure 2 . Patients with and without preoperative neck US did not differ in the rate of CND (15.8% ((18ϩ19)/234) vs. 15.6% (36/231) respectively). In contrast, the use of preoperative neck US significantly impacted on the operative management of the lateral neck. Patients with a preoperative neck US were more likely to have a LND compared to those without (13.2% ((12ϩ19)/ 234) vs. 0.9% (2/231), P Ͻ .001).
A detailed flowchart showing the management of the lateral neck is shown in Figure 3 . Of the 234 patients who had preoperative neck US, 48 patients had abnormal lateral compartment nodes detected. Of these, 31 patients underwent LND. Of the 17 patients that did not have LND: 8 patients had benign fine needle biopsy, 6 patients had the 'abnormal' lymph node sampled intraoperatively and found to be benign on frozen section, 1 patient had known Hodgkin's lymphoma, 1 had metastatic prostate cancer and 1 patient had a preoperative decision for RAI over neck dissection. No patient with a normal preoperative lateral neck on US had LND. Of the 31 patients who had lateral ND, preoperative FNA was performed in 17 patients; 16 of which were malignant, 1 was benign. The remaining 14 patients did not have a preoperative FNA as the findings on US were deemed suspicious enough to warrant ND. Nine of these 14 patients had lateral neck metastases on final histopathological evaluation.
Nodal Disease and Quality of Neck Dissection
The quality of neck dissection (defined by the mean number of nodes resected per neck dissection) was similar in both groups. The mean number of side adjusted positive nodal disease in the central and lateral compartments did not differ in patients with and without a preoperative neck ultrasound (P ϭ .637, P ϭ .988 respectively). Twentyseven patients had false negative preoperative US. Most these (n ϭ 25) were in level 6 of the central neck (N1a), 1 was in level 7 of the central neck (N1b) and 1 patient had a borderline lateral LN sampled intraoperatively .
RAI therapy
Patients without a preoperative neck US were more likely to receive postoperative RAI therapy compared to patients who had a preoperative neck US (P ϭ .004). In patients that received RAI, the mean RAI administered activity did not differ between the two groups (P ϭ .713).
Response to initial therapy
Response to Therapy was significantly better in patients with a preoperative neck US (Table 1) . Two hundred and twenty six patients (96.6%) with a preoperative neck US were classified as NED within 18 months compared to 205 patients (88.7%) without a preoperative neck US (P ϭ .005). Biochemical and structural persistence were also lower in the group with preoperative US (1.7% vs. 5.6%, 1.7 vs. 5.6% respectively).
Neck Dissection for Recurrent or Persistent disease
In addition to better Response to Therapy, patients who had preoperative US were significantly less likely to have a subsequent lateral neck dissection for recurrent or persistent disease. Figure 4 shows details of 12 patients who required neck dissection. Ten patients from the no preoperative US group returned to operating room compared to 2 patients (4.3% vs. 0.9%, P ϭ .018) that had a preoperative neck US. Overall median follow up for this group was 38 months. No patient with a normal preop- erative neck US required a neck dissection following treatment for recurrent or persistent disease.
Discussion
Occult metastases in patients with DTC are common occurring in 20%-90% of patients (7, 8) . Despite this high frequency, occult central or lateral metastases have no effect on outcome and are largely thought to be indolent disease (3). However, lateral compartment location and macrometastases (nodes Ͼ 1cm in size) are thought to confer worse prognosis, especially in older patients (9, 10) . This is reflected in the AJCC staging system where patients over 45 years of age are stage III if they have central neck disease and stage IV if they have lateral neck disease. It is therefore important to carefully assess the lateral neck by clinical examination supplemented with imaging in patients with DTC. In the assessment of neck nodes, it has been shown that preoperative neck ultrasound has improved sensitivity compared to preoperative physical examination for the diagnosis of nodal disease. Kouvaraki et al demonstrated that preoperative neck US detected LN metastases in neck compartments believed to be uninvolved by physical examination in 21% of patients undergoing primary thyroid surgery (11) and the detection of preoperative US cervical lymph nodes potentially alters the surgical management in up to 30% of patients (11, 12) . Furthermore, diagnosis of positive regional lymph nodes has been associated with poorer outcomes, particularly in older patients (2, 3) . As a result of these studies, the ATA recommends preoperative neck US to assess the lateral neck compartment lymph nodes for all patients undergoing thyroidectomy for thyroid cancer (1). However, it should be noted that the use of US in the assessment of the central neck lymph nodes is much less sensitive (13) . In the present study, the overall sensitivity and specificity of US assessment of both lateral and central neck nodes was 57% and 88% respectively. The reduced sensitivity was largely due to the failure to detect positive nodes in the central neck. Twenty-seven patients had false negative preoperative US. Most these (n ϭ 25) were in level 6 of the central neck (N1a), 1 was in level 7 of the central neck (N1b) and 1 patient had a borderline lateral LN sampled intraoperatively (N1b). This further illustrates the limitations of preop US in assessing the central compartment neck nodes.
Sonographic features suggestive of abnormal metastatic lymph nodes include loss of the fatty hilus, a rounded rather than oval shape, hypoechogenicity, cystic change, calcifications, and peripheral vascularity. However, no single feature is adequately sensitive for detection of lymph nodes with metastatic thyroid cancer (14, 15) . US has been shown to be superior to other imaging modalities such as computer tomography (CT), magnetic resonance imaging (MRI), (MRI) and positron emission tomography (PET) for the detection of cervical lymph node metastases where sensitivities range between 30%-40% (16). US examination also has the additional benefit of being easily combined with fine needle aspirate biopsy (FNAB). US with FNAB is a more accurate method for assessment of neck node status. A Dutch study of 120 patients found the specificity of combined US and FNAB results was significantly higher than US alone; 92.9% compared with 60.0% (17) . Our institution increasingly utilizes FNAB cytological confirmation of sonographically suspicious cervical lymph nodes to guide the extent of neck dissection. While the utility of US in regional LN diagnosis has been established, how preoperative neck US changes prognosis is still unclear. At our institution, we have traditionally assessed the lateral neck by clinical examination and have only recently employed US assessment in selected patients. In the years 2009 to 2010 approximately 50% of our patients did not have preoperative lateral neck node assessment prior to surgery. This therefore gave us an ideal and unique opportunity to investigate the ATA recommendations with regards to the utility and efficacy of preoperative neck US. By directly comparing patients who had and those that did not have preoperative neck US we were able to directly compare response to therapy between groups and also directly compare subsequent later neck dissection rates for persistent or recurrent neck disease. This study also gave us an opportunity to compare the therapeutic outcome, with reference to disease specific and recurrence free survival, as well as the frequency of neck dissection in each group.
In our cohort, suspicious cervical LNs were identified in 24.4% of patients with normal clinical neck exams on preoperative US, a finding consistent with the literature; preoperative US identifies suspicious cervical lymph nodes in 20%-31% of cases (2, 18, 19) . One of the major findings of our study was that patients with a preoperative neck US had a higher rate of lateral neck dissection (13.2% vs. 0.9%, P Ͻ .001) and a significantly better Response to Therapy than patients without preoperative US (P ϭ .005).
In addition, patients who had preoperative neck US were less likely to return to the OR for recurrent or persistent disease (0.9% vs. 4.3%, P ϭ .018). Another important finding from our study was that those who did not have a preoperative neck US were more likely to receive postoperative RAI (42.9 vs. 29.9%, P ϭ .004). Patients without a preoperative lateral neck node assessment by US were more likely to have an elevated Tg following total thyroidectomy and this likely led to the initiation of adjuvant RAI. This is supported by the finding that patients with a preoperative neck US have a significantly lower postoperative Tg value (0.094 ug/ml ϩ/-0.334) compared to patients without preoperative US (0.602 ug/ml ϩ/-2.64) (P ϭ .004). These 3 observations (improved Response to Therapy, reduced rate of subsequent neck dissection for persistent or recurrent neck disease and reduced RAI usage) support the recommendation that preoperative assessment of the lateral neck detects impalpable lateral neck disease thereby identifying select patients who will benefit from subsequent lateral neck dissection.
These results therefore provide some justification for the use of preoperative ultrasound. However, one could also argue that the use of preoperative ultrasound results in many patients being overtreated with some patients having lateral neck dissections unnecessarily. While preoperative US decreases return to OR for persistent or recurrent disease, it is not clear if early detection and surgical intervention results in improved survival. When we compare the DSS of our preoperative US cohort vs the no preoperative US cohort, the 3 year DSS are identical at 100% for both groups. Longer follow up of both groups is required to better define the impact of this improved Response to Therapy on survival. It is possible that early detection results in no improvement in survival compared to a management strategy of only carrying out a lateral neck dissection when nodes become clinically palpable. In addition, early detection by preoperative US may result in some patients having a neck dissection unnecessarily. For example, in our study, neck dissection was performed initially in 13.2% of preoperative US patients (31/234). In the no preoperative US cohort, 2 patients required neck dissection initially but a further 10 required a neck dissection later on making an overall neck dissection rate of 5.2% (12/231). This suggests that over 50% of the preoperative US patients may have underwent LND for potentially indolent disease.
Therefore one can argue that both management strategies (1. preoperative US and early detection of nodes with early LND and 2. no preoperative US with salvage LND when clinically palpable nodes become apparent) are equally effective in terms of survival. The early detection strategy has the potential advantage in terms of patient counseling; as these patients can be reassured after the first Tg blood measurement and postoperative US assessment that they have a negligible risk of recurrence and can thus have less intense follow up. The same cannot be said for the late detection strategy (no preoperative US cohort) as we do not know which of these patients will recur and therefore all patients in this cohort require long term follow up. The benefit of the late detection strategy means that all LND will be performed for clinically detectable disease, rather than for subclinicial disease.
In conclusion, our study demonstrates that the use of preoperative neck node assessment by US facilitates a more complete surgical resection to the regional lymph nodes in patients with DTC. This results in improved Response to Therapy, reduces adjuvant RAI treatments and reduces regional recurrence rates. Such a policy is beneficial for patient counseling, limits subsequent follow up tests and allows for early patient discharge. However, although this policy results in improved Response to Therapy, it remains unclear if there is any impact on survival.
